Ifosfamide (IFO) in the treatment of metastatic hormone refractory prostate cancer

被引：0
|
作者：
KellokumpuLehtinen, P
Lehtinen, T
Tammela, T
机构：
[1] TAMPERE UNIV HOSP,DEPT ONCOL,TAMPERE,FINLAND
[2] TAMPERE UNIV HOSP,DEPT UROL,TAMPERE,FINLAND
来源：
EUROPEAN JOURNAL OF CANCER | 1997年 / 33卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：128 / 128
页数：1
相关论文
共 50 条
  • [11] Current place of chemotherapy in the treatment of hormone-refractory metastatic prostate cancer.
    Breton, X
    Lechevallier, E
    Coulange, C
    [J]. PROGRES EN UROLOGIE, 2005, 15 (03): : 398 - 404
  • [12] The role of doxorubicin and epirubicin for the treatment of patients with metastatic hormone-refractory prostate cancer
    Petrioli, Roberto
    Pascucci, Alessandra
    Francini, Edoardo
    Fiaschi, Anna Ida
    Sciandivasci, Angela
    Miano, Salvatora
    Marsili, Stefania
    Francini, Guido
    [J]. ANNALS OF ONCOLOGY, 2007, 18 : 74 - 74
  • [13] The role of doxorubicin and epirubicin in the treatment of patients with metastatic hormone-refractory prostate cancer
    Petrioli, Roberto
    Fiaschi, Anna Ida
    Francini, Edoardo
    Pascucci, Alessandra
    Francini, Guido
    [J]. CANCER TREATMENT REVIEWS, 2008, 34 (08) : 710 - 718
  • [14] Combined Cryoablation and GM-CSF Treatment for Metastatic Hormone Refractory Prostate Cancer
    Si, Tongguo
    Guo, Zhi
    Hao, Xishan
    [J]. JOURNAL OF IMMUNOTHERAPY, 2009, 32 (01) : 86 - 91
  • [15] PHASE-II TRIAL OF IFOSFAMIDE IN THE TREATMENT OF METASTATIC HORMONE-REFRACTORY PATIENTS WITH PROSTATIC-CANCER
    MAHJOUBI, M
    AZAB, M
    GHOSN, M
    THEODORE, C
    DROZ, JP
    [J]. CANCER INVESTIGATION, 1990, 8 (05) : 477 - 481
  • [16] Systemic treatment of hormone refractory prostate cancer
    H. Rübben
    A. Bex
    T. Otto
    [J]. World Journal of Urology, 2001, 19 : 99 - 110
  • [17] Systemic treatment of hormone refractory prostate cancer
    Rübben, H
    Bex, A
    Otto, T
    [J]. WORLD JOURNAL OF UROLOGY, 2001, 19 (02) : 99 - 110
  • [18] Advances in the treatment of hormone refractory prostate cancer
    Petrylak, Daniel P.
    [J]. CANCER INVESTIGATION, 2007, 25 : 19 - 19
  • [19] Treatment options in hormone-refractory metastatic prostate carcinoma
    Fusi, A
    Procopio, G
    Della Torre, S
    Ricotta, R
    Bianchini, G
    Salvioni, R
    Ferrari, L
    Martinetti, A
    Savelli, G
    Villa, S
    Bajetta, E
    [J]. TUMORI JOURNAL, 2004, 90 (06): : 535 - 546
  • [20] The Effect of Multiplicity of Metastatic Sites on Hormone Refractory Prostate Cancer
    Halim, Amal
    [J]. MIDDLE EAST JOURNAL OF CANCER, 2012, 3 (04) : 101 - 108
12345